Cargando…
The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis()
Onychomycosis is a common disease, accounting for up to 50% of all ungual pathologies. We have been developing a clinical trial (ClinicalTrials.gov: NCT01528813) using a 2940nm Er:YAG laser to fractionally ablate human nails in vivo, aiming to increase topical amorolfine lacquer delivery to the nail...
Autores principales: | de Morais, Orlando Oliveira, Costa, Izelda Maria Carvalho, Gomes, Ciro Martins, Shinzato, Dayane Higa, Ayres, Guilherme Marreta Cavalcanti, Cardoso, Rayane Marques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798374/ https://www.ncbi.nlm.nih.gov/pubmed/24173203 http://dx.doi.org/10.1590/abd1806-4841.20131932 |
Ejemplares similares
-
Amorolfine vs. ciclopirox – lacquers for the treatment of onychomycosis
por: Tabara, Katarzyna, et al.
Publicado: (2015) -
Periocular rejuvenation using a unique non-ablative long-pulse 2940 nm Er:YAG laser
por: Badawi, Ashraf, et al.
Publicado: (2021) -
Novel treatment of Hori's nevus: A combination of fractional nonablative 2,940-nm Er:YAG and low-fluence 1,064-nm Q-switched Nd:YAG laser
por: Tian, Brian Wei Cheng Anthony
Publicado: (2015) -
The Efficacy and Safety of Ablative Fractional Resurfacing Using a 2,940-Nm Er:YAG Laser for Traumatic Scars in the Early Posttraumatic Period
por: Kim, Sun Goo, et al.
Publicado: (2012) -
Randomized Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Short-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminium Garnet Laser and Amorolfine Nail Lacquer for Onychomycosis
por: Park, Kui Young, et al.
Publicado: (2017)